In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.
Saved in:
| Title: | In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types. |
|---|---|
| Authors: | Matossian MD; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Chang T; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Wright MK; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Burks HE; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Elliott S; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Sabol RA; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Wathieu H; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Windsor GO; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Alzoubi MS; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., King CT; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Bursavich JB; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Ham AM; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Savoie JJ; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Nguyen K; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Baddoo M; Cancer Genetics Program, Tulane University School of Medicine, New Orleans, LA, USA., Flemington E; Cancer Genetics Program, Tulane University School of Medicine, New Orleans, LA, USA., Sirenko O; Molecular Devices LLC, San Jose, CA, USA., Cromwell EF; Protein Fluidics Inc, Burlingame, CA, USA., Hebert KL; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Lau F; Department of Surgery, Section of Plastic & Reconstructive Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Izadpanah R; Tulane Cancer Center, New Orleans, LA, USA., Brown H; Innogenomics Technologies LLC, New Orleans, LA, USA., Sinha S; Innogenomics Technologies LLC, New Orleans, LA, USA., Zabaleta J; Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Riker AI; Cancer Service Line, Anne Arundel Medical Center, Luminis Health, DeCesaris Cancer Institute, Annapolis, MD, USA., Moroz K; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA.; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Miele L; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Zea AH; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Ochoa A; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Bunnell BA; Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, USA., Collins-Burow BM; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Cancer Center, New Orleans, LA, USA., Martin EC; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Burow ME; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA. mburow@tulane.edu. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Jan; Vol. 24 (1), pp. 127-144. Date of Electronic Publication: 2021 Aug 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1699-3055 |
|---|---|
| DOI: | 10.1007/s12094-021-02677-8 |
